Your session is about to expire
← Back to Search
Epilepsy Cohort for Epilepsy
Study Summary
This trial aims to better understand depression by studying brain activity in patients with epilepsy and treatment-resistant depression. The researchers are using advanced artificial intelligence techniques to analyze the data and develop new treatment strategies. Their goal
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals who are 85 years of age and older eligible to participate in this trial?
"To be eligible for inclusion in this study, participants must range from 21 to 70 years old."
Can individuals such as myself participate in this clinical study?
"The research study aims to recruit 58 individuals diagnosed with epilepsy, aged between 21 and 70. Specifically, eligible participants include adults planning intracranial seizure monitoring after giving informed consent for the Epilepsy cohort and those currently engaged in our Deep Brain Stimulation (DBS) trial for depression within the Depression cohort."
What is the overall count of individuals involved in this research endeavor?
"Indeed, information sourced from clinicaltrials.gov reveals that this investigation is actively seeking eligible participants. Initially shared on 7th March 2023 and last revised on 4th April 2024, the trial aims to enroll a total of 58 individuals across one designated site."
Share this study with friends
Copy Link
Messenger